Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

Share Price is delayed by 15 minutes
Get Live Data
6.25    0.00 (0.00%)
Bid:
6.00
Ask:
6.50
Spread: 0.50 (8.333%)
Market Cap: £6.46m
OPTI Live PriceLast checked at - London Stock Exchange

Intraday OptiBiotix Health Share Chart

Trading Update

8 Feb 2012 07:00

CERES MEDIA INTERNATIONAL PLC ("Ceres", "the Company" or "the Group") Trading update

Further to the announcement made 19 December 2011, the Company has now resolved the technical issues associated with the production of its TierraFilm range and has taken delivery of stock of this product and, upon receipt of an order, can be immediately delivered. The TierraFilm products are currently being trialled by distributors, printers and end users and the feedback received by the Company from the trials has been positive.

TierraFilm products are designed as an environmental alternative to the coated paper or oil based materials typically used in the print industry. They are manufactured using Sustainable Forestry InitiativeTM (SFI) certified raw materials and can be disposed of in existing biodegradation, composting or Energy From Waste systems removing the need to landfill.

Delays in scaling up production and bringing TierraFilm to the market together with the slower than anticipated take-up of Gossyp and Chorus products, as previously announced, have had a consequential impact on the Company's working capital position, which the board is monitoring closely. The board has also taken action to reduce the cost base of the Company in order to conserve its cash position.

The sales of Chorus and Gossyp, the Company's other principal products, continue to be significantly below the board's expectations and the Company is continuing to refocus its sales strategy in relation to these products.

A further update will be made in due course.

For further information, please contact:

Ceres Media International PLC Tel: 020 3178 5622 Alex Dowdeswell Leslie Barber Nominated Adviser Tel: 020 7148 7900 Cairn Financial Advisers LLP Jo Turner / Liam Murray Broker Tel: 020 3002 2070 First Columbus LLP

Chris Crawford / Kelly Gardiner Financial PR Tel: 020 7556 1063 De Facto Financial

Mike Wort / Anna Dunphy

XLON
Date   Source Headline
23rd Jun 20155:00 pmRNSHolding(s) in Company
17th Jun 20154:59 pmRNSExercise of Warrants and Issue of Equity
12th Jun 20152:05 pmRNSHolding(s) in Company
9th Jun 20157:00 amRNSStrategic Development and Commercial Alliance
5th Jun 20152:32 pmRNSExercise of Warrants and Issue of Equity
3rd Jun 20155:50 pmRNSHolding(s) in Company
2nd Jun 20157:00 amRNSContract with multinational consumer goods company
29th May 20157:00 amRNSFinal Results
28th May 20157:00 amRNSNew patent filings
26th May 20157:01 amRNSExercise of Warrants and Issue of Equity
15th May 20153:22 pmRNSHolding(s) in Company
13th May 20157:00 amRNSNotice of Results
21st Apr 20152:24 pmRNSExercise of Warrants and Issue of Equity
17th Apr 20157:00 amRNSResearch Update
14th Apr 20157:00 amRNSUK Investor Show attendance
10th Apr 20154:35 pmRNSPrice Monitoring Extension
8th Apr 20155:26 pmRNSHolding(s) in Company
31st Mar 20155:32 pmRNSGrant of Options
25th Mar 201512:54 pmRNSHolding(s) in Company
20th Mar 201510:32 amRNSExercise of Warrants and Issue of Equity
10th Mar 20157:02 amRNSContract signed with NIZO Food Research
23rd Feb 20157:00 amRNSInvestor Teach In
18th Feb 20157:00 amRNSBoard Appointment
4th Feb 20154:03 pmRNSHolding(s) in Company
21st Jan 20157:00 amRNSJoint venture with Nizo Food Research
20th Jan 20153:23 pmRNSExercise of Warrants and Issue of Equity
15th Jan 20157:00 amRNSAdditions to Scientific Advisory Group
9th Jan 20152:24 pmRNSExercise of Warrants and Issue of Equity
15th Dec 20147:00 amRNSCompletion of ethics approval & study recruitment
10th Dec 20147:00 amRNSChange of Adviser
2nd Dec 20147:00 amRNSSuccessful completion of pre-clinical studies
28th Nov 20142:34 pmRNSHolding(s) in Company
28th Nov 20147:00 amRNSProduct showcased at Health Ingredients Europe
27th Nov 20144:57 pmRNSExercise of Warrants
25th Nov 20147:00 amRNSAppointment of Non-Executive Director
18th Nov 20147:00 amRNSAppointment of Head of Research
14th Nov 20142:46 pmRNSIssue of Equity
11th Nov 20147:00 amRNSContract Signed to Start Clinical Studies
28th Oct 20147:00 amRNSIncorporation of Weight Management Formulation
20th Oct 20147:00 amRNSScientific Advisory Group
1st Oct 20144:08 pmRNSExercise of Warrants
17th Sep 20147:00 amRNSContract signed with Nizo Food Research
5th Aug 20147:00 amRNSFirst day of dealings on AIM
4th Aug 20143:27 pmRNSChange of Name
4th Aug 201411:19 amRNSResult of General Meeting
18th Jul 20144:08 pmRNSExercise of Warrants and Issue of Equity
18th Jul 20147:30 amRNSSchedule 1 - Ducat Ventures plc
18th Jul 20147:30 amRNSRestoration - Ducat Ventures plc
18th Jul 20147:00 amRNSPublication of Admission Document & Restoration...
18th Jul 20147:00 amRNSHalf Yearly Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.